NAT2 polymorphisms and sporadic colorectal cancer survival

Journal of Gastrointestinal and Liver Diseases

Volumn 19, Issue 4, 2010, Pages 361-368

  Osian, Gelu ^a   Procopciuc, Lucia ^a   Vlad, Liviu ^a   Iancu, Cornel ^a   Cristea, Paul G ^a   Mocan, Teodora ^a   Mocan, Lucian ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Acetylator; Dukes MAC stages; NAT2; Sporadic colorectal cancer; Survival

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; NAT2 PROTEIN, HUMAN;

ACETYLATION; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; CORRELATION ANALYSIS; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SURVIVAL RATE; CANCER STAGING; COLONOSCOPY; COLORECTAL TUMOR; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHENOTYPE; PROSPECTIVE STUDY; REGISTER; RETROSPECTIVE STUDY; ROMANIA; TIME; TREATMENT OUTCOME;

ACETYLATION; AGED; ARYLAMINE N-ACETYLTRANSFERASE; COLONOSCOPY; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PHENOTYPE; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; REGISTRIES; RETROSPECTIVE STUDIES; ROMANIA; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79955659840     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Potter JD. Colorectal cancer: molecules and populations. J Natl Cancer Inst 1999;91:916-932.
2. Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001;10:725-731.
3. Freedman A. Somatic alterations and metabolic polymorphisms. In: Vineis P, Malats M, Lang A, et al. (eds). Metabolic Polymorphisms and Susceptibility to Cancer. Lyon: IARC Scientific Publ 1999. vol. 148, 37-50
4. Windmill KF, Gaedigk A, Hall PM, Samaratunga H, Grant DM, McManus ME. Localization of N-acetyltransferases NAT1 and NAT2 in human tissues. Toxicol Sci 2000;54:19-29.
5. Hein DW, Doll MA, Fretland AJ, et al. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev 2000;9:29-42.
6. Barrett JH, Smith G, Waxman R, et al; Colorectal Cancer Study Group. Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancer. Carcinogenesis 2003;24:275-282.
7. Blum M, Grant DM, McBride W, Heim M, Meyer UA. Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol 1990;9:193-203.
8. Hickman D, Risch A, Buckle V, et al. Chromosomal localization of human genes for arylamine N-acetyltransferase. Biochem J 1994;297:441-445.
9. Pande JN, Pande A, Singh SP. Acetylator status, drug metabolism and disease. Natl Med J India 2003;16:24-26.
10. Layton DW, Bogen KT, Knize MG, Hatch FT, Johnson VM, Felton JS. Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis 1995;16:39-52.
11. Patrianakos C, Hoffmann D. Chemical studies on tobacco smoke. LXIV. On the analysis of aromatic amines in cigarette smoke. J Anal Toxicol 1979;3:150-154.
12. Manabe S, Tohyama K, Wada O, Aramaki T. Detection of a carcinogen, 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP), in cigarette smoke condensate. Carcinogenesis 1991;12:1945-1947.
13. Hughes HB, Biehl JP, Jones AP, Schmidt LH. Metabolism of isoniazid in man as related to the occurrence of peripheral neuritis. Am Rev Tuberc 1954;70: 266-273
14. Jenne JW. Partial purification and properties of the isoniazid transacetylase in human liver: its relationship to the acetylation of p-aminosalicylic acid. J Clin Investig 1965;44:1992-2002.
15. Evans DA, White TA. Human acetylation polymorphism. J Lab Clin Med 1964;63:394-403.
16. Weber WW, Hein DW. Clinical pharmacokinetics of isoniazid. Clin Pharmacokinet 1979;4:401-422.
17. Grant DM, Hughes NC, Janezic SA, et al. Human acetyltransferase polymorphisms. Mutat Res 1997;376:61-70.
18. Hirvonen A. Polymorphic NATs and cancer predisposition. In: Vineis P, Malats M, Lang A et al (eds). Metabolic Polymorphisms and Susceptibility to Cancer. Lyon: IARC Scientific Publ 1999: 251-270.
19. Cascorbi I, Drakoulis N, Brockmoller J, Maurer A, Sperling K, Roots I. Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity. Am J Hum Genet 1995;57:581-592.
20. Cascorbi I, Roots I. Pitfalls in N-acetyltransferase 2 genotyping. Pharmacogenetics 1999;9:123-127.
21. Deguchi T. Sequences and expression of alleles of polymorphic arylamine N-acetyltransferase of human liver. J Biol Chem 1992;267:18140-18147.
22. Ferguson RJ, Doll MA, Rustan TD, Gray K, Hein DW. Cloning, expression, and functional characterization of two mutant (NAT2 191 and NAT2 341/803) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles. Drug Metab Dispos 1994;22:371-376
23. Purewal M, Fretland AJ, Schut HA, Hein DW, Wargovich MJ. Association between acetylator genotype and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) DNA adduct formation in colon and prostate of inbred Fischer 344 and Wistar Kyoto rats. Cancer Lett 2000;149:53-60.
24. Lang NP, Chu DZ, Hunter CF, Kendall DC, Flammang TJ, Kadlubar FF. Role of aromatic amine acetyltransferase in human colorectal cancer. Arch Surg 1986;121:1259-1261.
25. Ilett KF, David BM, Detchon P, Castleden WM, Kwa R. Acetylation phenotype in colorectal carcinoma. Cancer Res 1987;47:1466-1469.
26. Frazier ML, O'Donnell FT, Kong S, et al. Age-associated risk of cancer among individuals with N-acetyltransferase 2 (NAT2) mutations and mutations in DNA mismatch repair genes. Cancer Res 2001;61:1269-1271.
27. Lee EJ, Zhao B, Seow-Choen F. Relationship between polymorphism of N-acetyltransferase gene and susceptibility to colorectal carcinoma in a Chinese population. Pharmacogenetics 1998;8:513-517.
28. Lahiri DK, Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991;19:5444.
29. Osian G, Procopciuc L, Vlad L. NAT2 gene polymorphism and sporadic colorectal cancer: prevalence, tumor stage and prognosis. A preliminary study in 70 patients. J Gastrointestin Liver Dis 2006;15:347-353.
30. Gil JP, Lechner MC. Increased frequency of wild-type arylamine-N-acetyltransferase allele NAT2*4 homozygotes in Portuguese patients with colorectal cancer. Carcinogenesis 1998;19:37-41.
31. Tamer L, Ercan B, Ateş NA, et al. N-acetyltransferase 2 gene polymorphism in patients with colorectal carcinoma. Cell Biochem Funct 2006;24:131-135.
32. Kiss I, Németh A, Bogner B, et al. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer. Anticancer Res 2004;24:3965-3970.
33. Slattery ML, Potter JD, Samowitz W, Bigler J, Caan B, Leppert M. NAT2, GSTM-1, cigarette smoking, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 1998;7:1079-1084.
34. Katoh T, Boissy R, Nagata N, et al. Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma. Int J Cancer 2000;85:46-49.
35. Butler WJ, Ryan P, Roberts-Thomson IC. Metabolic genotypes and risk for colorectal cancer. J Gastroenterol Hepatol 2001;16:631-635.
36. Tiemersma EW, Kampman E, Bueno de Mesquita HB, et al. Meat consumption, cigarette smoking, and genetic susceptibility in the etiology of colorectal cancer: results from a Dutch prospective study. Cancer Causes Control 2002;13:383-393.
37. Hardingham JE, Butler WJ, Roder D, et al. Somatic mutations, acetylator status, and prognosis in colorectal cancer. Gut 1998;42:669-672.
38. Hubbard AL, Harrison DJ, Moyes C, et al. N-acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions. Gut 1997; 41:229-234.